Cygnal Therapeutics Appoints Pearl S. Huang as Chief Executive Officer

CAMBRIDGE, Mass., Jan. 8, 2019 -- (Healthcare Sales & Marketing Network) -- Cygnal Therapeutics, a biotechnology company pioneering the field of exoneural biology for the treatment of cancer, autoimmune conditions, inflammation, and other diseases, today ... Biopharmaceuticals, Personnel Cygnal Therapeutics, exoneural biology, exoneural
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news